Your browser doesn't support javascript.
loading
Mortalidad intrahospitalaria por accidente cerebrovascular / In-hospital mortality due to stroke
Rodríguez Lucci, Federico; Pujol Lereis, Virginia; Ameriso, Sebastián; Povedano, Guillermo; Díaz, María F.; Hlavnicka, Alejandro; Wainsztein, Néstor A.; Ameriso, Sebastián F..
  • Rodríguez Lucci, Federico; FLENI. Instituto de Investigaciones Neurológicas Dr. Raúl Carrea. Buenos Aires. AR
  • Pujol Lereis, Virginia; FLENI. Instituto de Investigaciones Neurológicas Dr. Raúl Carrea. Buenos Aires. AR
  • Ameriso, Sebastián; FLENI. Instituto de Investigaciones Neurológicas Dr. Raúl Carrea. Buenos Aires. AR
  • Povedano, Guillermo; FLENI. Instituto de Investigaciones Neurológicas Dr. Raúl Carrea. Buenos Aires. AR
  • Díaz, María F.; FLENI. Instituto de Investigaciones Neurológicas Dr. Raúl Carrea. Buenos Aires. AR
  • Hlavnicka, Alejandro; FLENI. Instituto de Investigaciones Neurológicas Dr. Raúl Carrea. Buenos Aires. AR
  • Wainsztein, Néstor A.; FLENI. Instituto de Investigaciones Neurológicas Dr. Raúl Carrea. Buenos Aires. AR
  • Ameriso, Sebastián F.; FLENI. Instituto de Investigaciones Neurológicas Dr. Raúl Carrea. Buenos Aires. AR
Medicina (B.Aires) ; 73(4): 331-334, jul.-ago. 2013. tab
Article in Spanish | LILACS | ID: lil-694789
RESUMEN
La mortalidad global por accidente cerebrovascular (ACV) ha disminuido en las últimas tres décadas, probablemente debido a un mejor control de los factores de riesgo vascular. La mortalidad hospitalaria por ACV ha sido tradicionalmente estimada entre 6 y 14% en la mayoría de las series comunicadas. Sin embargo, los datos de ensayos clínicos recientes sugieren que esta cifra sería sustancialmente menor. Se revisaron datos de pacientes internados con diagnóstico de ACV del Banco de Datos de Stroke de FLENI y los registros institucionales de mortalidad entre los años 2000 y 2010. Los subtipos de ACV isquémicos se clasificaron según criterios TOAST y los ACV hemorrágicos en hematomas intrapanquimatosos, hemorragias subaracnoideas aneurismáticas, malformaciones arteriovenosas y otros hematomas intraparenquimatosos. Se analizaron 1514 pacientes, 1079 (71%) con ACV isquémico (grandes vasos 39%, cardioembólicos 27%, lacunares 9%, etiología indeterminada 14%, otras etiologías 11%) y 435 (29%) con ACV hemorrágico (intraparenquimatosos 27%, hemorragia subaracnoidea 30%, malformaciones arteriovenosas 25% y otros hematomas espontáneos 18%). Se registraron 38 muertes intrahospitalarias (17 ACV isquémicos y 21 ACV hemorrágicos), representando una mortalidad global del 2.5% (1.7% en ACV isquémicos y 4.8% en ACV hemorrágicos). No se registraron muertes asociadas al uso de fibrinolíticos endovenosos. La mortalidad intrahospitalaria en pacientes con ACV isquémico y hemorrágico en nuestro centro fue baja. El manejo en un centro dedicado a las enfermedades neurológicas y el enfoque multidisciplinario por personal médico y no médico entrenado en el cuidado de la enfermedad cerebrovascular podrían explicar, al menos en parte, estos resultados.
ABSTRACT
Overall mortality due to stroke has decreased in the last three decades probable due to a better control of vascular risk factors. In-hospital mortality of stroke patients has been estimated to be between 6 and 14% in most of the series reported. However, data from recent clinical trials suggest that these figures may be substantially lower. Data from FLENI Stroke Data Bank and institutional mortality records between 2000 and 2010 were reviewed. Ischemic stroke subtypes were classified according to TOAST criteria and hemorrhagic stroke subtypes were classified as intraparenchymal hematoma, aneurismatic subarachnoid hemorrhage, arterio-venous malformation, and other intraparenchymal hematomas. A total of 1514 patients were studied. Of these, 1079 (71%) were ischemic strokes,39% large vessels, 27% cardioembolic, 9% lacunar, 14% unknown etiology, and 11% others etiologies. There were 435 (29%) hemorrhagic strokes, 27% intraparenchymal hematomas, 30% aneurismatic subarachnoid hemorrhage, 25% arterio-venous malformation, and 18% other intraparenchymal hematomas. Moreover, 38 in-hospital deaths were recorded (17 ischemic strokes and 21 hemorrhagic strokes), accounting for 2.5% overall mortality (1.7% in ischemic strokes and 4.8% in hemorrhagic strokes). No deaths occurred associated with the use of intravenous fibrinolytics occurred. In our Centre in-hospital mortality in patients with stroke was low. Management of these patients in a Centre dedicated to neurological diseases along with a multidisciplinary approach from medical and non-medical staff trained in the care of cerebrovascular diseases could, at least in part, account for these results.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Hospital Mortality / Stroke Type of study: Etiology study / Risk factors Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: South America / Argentina Language: Spanish Journal: Medicina (B.Aires) Journal subject: Medicine Year: 2013 Type: Article Affiliation country: Argentina Institution/Affiliation country: FLENI/AR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Hospital Mortality / Stroke Type of study: Etiology study / Risk factors Limits: Aged / Aged80 / Female / Humans / Male Country/Region as subject: South America / Argentina Language: Spanish Journal: Medicina (B.Aires) Journal subject: Medicine Year: 2013 Type: Article Affiliation country: Argentina Institution/Affiliation country: FLENI/AR